English Translation This is a translation of the original release in Japanese. In the event of any discrepancy, the original release in Japanese shall prevail. .
Note: This document is a translated version for reference purposes only. Therefore, any discrepancy may occur with the Japanese original version. Please refer to the. | May 10, 2023
EDEN PRAIRIE, Minn. (BUSINESS WIRE) #InVitroDiagnostic Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2022, and updated its financial outlook for its fis.
While Congress continues debate on the fiscal year (FY) 2009defense bills, the services continue their work on the Pentagon's2010 budget proposal in consultation with the Office of theSecretary of Defense and the Office of Management and Budget (OMB).As is typical during the annual process, the services were told tocut their budgets and programs from their original estimations.